Speak to an Expert - +63 9178276309
Multiple Sclerosis Treatment with hematopoietic stem cells
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis
https://jamanetwork.com/journals/jama/article-abstract/2720728
The baby girl Zhao Jiaxin was the first child in China to receive a cord blood transplant as a cure for a genetic form of irritable bowel disease that is often lethal to new-borns.
https://parentsguidecordblood.org/en/news/cord-blood-transplant-corrects-very-early-onset-irritable-bowel-disease
Cerebral palsy treatment with hematopoietic stem cells
Nerea's Story
The Placenta’s 2nd Life Your placenta can continue to provide therapeutic value and have a 2nd life if the afterbirth is not discarded as medical waste. Components isolated from the placenta, such as the umbilical cord blood, and the amniotic membrane, are already serving a valuable role in medicine today. Research continues to develop the therapeutic value of other components of the placenta. With our skills in cryopreservation, your placenta can be preserved for future applications in personalized medicine. The placenta’s 2nd life encompasses new treatments today and bio-banking for the future. We are rapidly moving into a new paradigm where the placenta is transitioning from biological waste to becoming a biological toolbox for cures.
A human clinical trial of an experimental stem cell therapy for coronavirus patients has been approved by the U.S. Food and Drug Administration. Read More